Skip to main content
$54.95 -$0.59 (-1.1%)

04:00 PM EST on 01/14/22

Pfizer Inc (NYSE:PFE)

CAPS Rating: 3 out of 5

A research-based pharmaceutical company, Pfizer discovers, develops, manufactures, and markets prescription medicines such as Lipitor, Celebrex, and Viagra.

Current Price $54.95 Mkt Cap $308.4B
Open $54.98 P/E Ratio 15.44
Prev. Close $54.95 Div. (Yield) $1.60 (2.9%)
Daily Range $54.51 - $55.38 Volume 27,072,545
52-Wk Range $33.36 - $61.71 Avg. Daily Vol. 45,556,341

Caps

How do you think NYSE:PFE will perform against the market?

Add Stock to CAPS Watchlist

All Players

5,599 Outperform
591 Underperform
 

All-Star Players

995 Outperform
69 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYSE:PFE Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

EnigmaDude (48.84)
Submitted September 01, 2021

One large cap healthcare stock to watch with 3% divy

poerqwa (< 20)
Submitted September 27, 2014

The stock has been underperforming for a while now. AstraZeneca and other pharma-peers are showing a nice growth(in stock price). The recent fail of Pfizer to take over AstraZeneca(AZN) and nothing special in the works, only proves to me that for the… More

Recent Community Commentary

Read the most recent pitches from players about PFE.

Recs

0
Member Avatar JohnnyCaffeine (< 20) Submitted: 1/13/2022 9:19:20 AM : Outperform Start Price: $55.49 NYSE:PFE Score: +0.85

Has a solid moat with respect to COVID vaccines, and those will keep going potentially as far as the eye can see as long as the virus is with us. Pfizer also has a very wide range of drugs, a long history, and should do great over time.

Recs

1
Member Avatar EnigmaDude (48.84) Submitted: 9/1/2021 2:18:25 PM : Outperform Start Price: $45.79 NYSE:PFE Score: +17.54

One large cap healthcare stock to watch with 3% divy

Recs

1
Member Avatar TMFbonefish (41.97) Submitted: 9/1/2021 12:07:30 PM : Outperform Start Price: $45.66 NYSE:PFE Score: +17.84

Cheaper than other large drugmakers and management has committed to double digit profit growth. If it can get there, and the vaccine matches the $2 billion annually that many analysts expect, the stock is dirt cheap below $50 per share.

Leaderboard

Find the members with the highest scoring picks in PFE.

Score Leader

flickib41

flickib41 (62.93) Score: +179.69

The Score Leader is the player with the highest score across all their picks in PFE.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
compfreak999 80.00 6/20/2008 Outperform 1Y $10.28 +435.26% +264.61% +170.65 1 Comment
SomersGOP < 20 6/23/2008 Outperform 1Y $10.32 +433.10% +263.05% +170.05 0 Comment
DrDrBob 89.42 6/23/2008 7/19/2008 Outperform 3Y $10.32 +433.10% +263.05% +170.05 0 Comment
GracieMD1998 < 20 6/23/2008 Outperform 1Y $10.32 +433.10% +263.05% +170.05 0 Comment
MATTALANKANE 77.99 6/23/2008 Outperform 5Y $10.32 +433.10% +263.05% +170.05 1 Comment
eckertbt < 20 6/23/2008 Outperform 3Y $10.32 +433.10% +263.05% +170.05 1 Comment
mooses2 50.58 6/23/2008 Outperform NS $10.32 +433.10% +263.05% +170.05 0 Comment
gtmitc 30.48 6/23/2008 Outperform 1Y $10.32 +433.10% +263.05% +170.05 0 Comment
AlIskandarani 75.25 6/12/2008 Outperform 1Y $10.44 +427.05% +257.53% +169.52 1 Comment
megamillion2 71.91 6/12/2008 Outperform 5Y $10.44 +427.05% +257.53% +169.52 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for PFE.